To establish whether ibrutinib directly affects CD40 signaling, we performed in vitro experiments in which CLL cells were pretreated with 0.1 μM ibrutinib for 24 h followed by co-culture with 3T3 or 3T40L fibroblasts for another 24 h. The gene discussed is CD40; the disease is B-cell chronic lymphocytic leukemia.